Literature DB >> 27702867

Patterns of physical activity and survival following cardiac resynchronization therapy implantation: the ALTITUDE activity study.

Daniel B Kramer1,2,3, Paul W Jones4, Tyson Rogers5, Susan L Mitchell2,3, Matthew R Reynolds1,6,7.   

Abstract

AIMS: Cardiac resynchronization therapy with implantable defibrillator backup (CRT-D) improves outcomes, but predictors and markers of response remain limited. Physical activity information collected by CRT devices may provide insights to CRT response and the relationship between activity changes and survival. METHODS AND
RESULTS: Patients entered into the LATITUDE remote monitoring system from 2008 to 2012 after receipt of a new CRT-D were eligible. Mean daily activity was calculated from LATITUDE uploads at baseline (first 3-10 days following implant) and 6 months (180-210 days). Pairwise differences for baseline-6-month activity were calculated, and survival according to quintiles of 6-month activity change was assessed. Cox regression was used to examine the adjusted association between survival and baseline-6-month activity change. A total of 26 509 patients were followed for a median of 2.3 years (mean age 70.2 ± 11.0 years, 70.7% male). Mean baseline activity was 66.2 ± 47.7 min/day, with mean paired increase at 6 months of 37.1 ± 48.2 min/day [95% CI (confidence interval), 36.5-37.6, P < 0.0001], though 15.5% of patients did not improve or worsened at 6 months. Survival at 3 years was significantly higher in the largest baseline-6-month activity change quintile vs. the lowest quintile (88.9% vs. 62.1%, log-rank P-value < 0.001). Adjusted for age and gender, higher 6-month activity change was associated with a lower risk of death (adjusted hazard ratios 0.65 per 30 min increase in activity, 95% CI, 0.63-0.67).
CONCLUSIONS: Change in physical activity between baseline and 6 months following CRT implantation is strongly associated with survival. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Cardiac resynchronization therapy; Exercise; Heart failure; Outcomes research; Remote monitoring

Mesh:

Year:  2017        PMID: 27702867      PMCID: PMC5834044          DOI: 10.1093/europace/euw267

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  22 in total

1.  A novel method--the activity log index--for monitoring physical activity of patients with heart failure.

Authors:  Veerichetty A Kadhiresan; Joseph Pastore; Angelo Auricchio; Stefan Sack; Annette Doelger; Steven Girouard; Julio C Spinelli
Journal:  Am J Cardiol       Date:  2002-06-15       Impact factor: 2.778

2.  Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.

Authors:  William T Abraham; James B Young; Angel R León; Stuart Adler; Alan J Bank; Shelley A Hall; Randy Lieberman; L Bing Liem; John B O'Connell; John S Schroeder; Kevin R Wheelan
Journal:  Circulation       Date:  2004-10-25       Impact factor: 29.690

3.  A mechanistic investigation into how long-term resynchronization therapy confers ongoing cardiac functional benefits and improved exercise capacity.

Authors:  Dominik Schlosshan; Diane Barker; Nigel Lewis; Chris Pepper; Lip-Bun Tan
Journal:  Am J Cardiol       Date:  2009-01-15       Impact factor: 2.778

4.  Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy.

Authors:  Cheuk-Man Yu; Gabe B Bleeker; Jeffrey Wing-Hong Fung; Martin J Schalij; Qing Zhang; Ernst E van der Wall; Yat-Sun Chan; Shun-Ling Kong; Jeroen J Bax
Journal:  Circulation       Date:  2005-09-06       Impact factor: 29.690

5.  Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.

Authors:  David J Whellan; Kevin T Ousdigian; Sana M Al-Khatib; Wenji Pu; Shantanu Sarkar; Charles B Porter; Behzad B Pavri; Christopher M O'Connor
Journal:  J Am Coll Cardiol       Date:  2010-04-27       Impact factor: 24.094

6.  Physical activity measured with implanted devices predicts patient outcome in chronic heart failure.

Authors:  Viviane M Conraads; Martijn A Spruit; Frieder Braunschweig; Martin R Cowie; Luigi Tavazzi; Martin Borggrefe; Michael R S Hill; Sandra Jacobs; Bart Gerritse; Dirk J van Veldhuisen
Journal:  Circ Heart Fail       Date:  2014-02-11       Impact factor: 8.790

7.  Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.

Authors:  Teresa De Marco; Eugene Wolfel; Arthur M Feldman; Brian Lowes; Michael B Higginbotham; Jalal K Ghali; Lynne Wagoner; Philip C Kirlin; Jerry D Kennett; Satish Goel; Leslie A Saxon; John P Boehmer; David Mann; Elizabeth Galle; Fred Ecklund; Patrick Yong; Michael R Bristow
Journal:  J Card Fail       Date:  2008-02       Impact factor: 5.712

8.  Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program.

Authors:  Wilfried Mullens; Richard A Grimm; Tanya Verga; Thomas Dresing; Randall C Starling; Bruce L Wilkoff; W H Wilson Tang
Journal:  J Am Coll Cardiol       Date:  2009-03-03       Impact factor: 24.094

9.  Cardiac-resynchronization therapy for the prevention of heart-failure events.

Authors:  Arthur J Moss; W Jackson Hall; David S Cannom; Helmut Klein; Mary W Brown; James P Daubert; N A Mark Estes; Elyse Foster; Henry Greenberg; Steven L Higgins; Marc A Pfeffer; Scott D Solomon; David Wilber; Wojciech Zareba
Journal:  N Engl J Med       Date:  2009-09-01       Impact factor: 91.245

Review 10.  An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure.

Authors:  John G Cleland; William T Abraham; Cecilia Linde; Michael R Gold; James B Young; J Claude Daubert; Lou Sherfesee; George A Wells; Anthony S L Tang
Journal:  Eur Heart J       Date:  2013-07-29       Impact factor: 29.983

View more
  5 in total

1.  Feasibility of Frailty Assessment Integrated with Cardiac Implantable Electronic Device Clinic Follow-up: A Pilot Investigation.

Authors:  Abdel Albakri; Ariela Orkaby; Michael A Rosenberg
Journal:  Gerontol Geriatr Med       Date:  2021-01-09

Review 2.  Accelerometer-assessed physical behavior and the association with clinical outcomes in implantable cardioverter-defibrillator recipients: A systematic review.

Authors:  Maarten Z H Kolk; Diana M Frodi; Tariq O Andersen; Joss Langford; Soeren Z Diederichsen; Jesper H Svendsen; Hanno L Tan; Reinoud E Knops; Fleur V Y Tjong
Journal:  Cardiovasc Digit Health J       Date:  2021-11-24

3.  Measuring Physical Activity With Implanted Cardiac Devices: A Systematic Review.

Authors:  Lindsey Rosman; Rachel Lampert; Samuel F Sears; Matthew M Burg
Journal:  J Am Heart Assoc       Date:  2018-05-17       Impact factor: 5.501

4.  Electrical remodelling and response following cardiac resynchronization therapy: A novel analysis of intracardiac electrogram using a quadripolar lead.

Authors:  Liam Toner; Darragh Flannery; Hariharan Sugumar; Michelle Ord; Tina Lin; David O'Donnell
Journal:  J Arrhythm       Date:  2018-04-27

5.  Device-measured physical activity data for classification of patients with ventricular arrhythmia events: A pilot investigation.

Authors:  Lucas Marzec; Sridharan Raghavan; Farnoush Banaei-Kashani; Seth Creasy; Edward L Melanson; Leslie Lange; Debashis Ghosh; Michael A Rosenberg
Journal:  PLoS One       Date:  2018-10-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.